Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis-Reference-Cited by-同舟云学术

Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis

Published:2016-08-31 Issue:51 Volume:7 Page:84142-84154
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ung Matthew H.¹,Wang George L.¹,Varn Frederick S.¹,Cheng Chao¹²³

Affiliation:

1. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, 03755 USA

2. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, 03755 USA

3. Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, 03766 USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cold Atmospheric Plasma Inhibits the Proliferation of CAL-62 Cells through the ROS-Mediated PI3K/Akt/mTOR Signaling Pathway;Science and Technology of Nuclear Installations;2022-06-08

2. Irisin Regulates Hepatic Glucose Metabolism via AMPK and PI3K/Akt Activation;Aquaculture Nutrition;2022-04-22

3. New insights into the cellular activities of Fndc5/Irisin and its signaling pathways;Cell & Bioscience;2020-03-30

4. Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth;Scientific Reports;2018-05-25

5. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition;Biochemical and Biophysical Research Communications;2017-04